These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8142917)

  • 1. Predictive statistics and artificial intelligence in the U.S. National Cancer Institute's Drug Discovery Program for Cancer and AIDS.
    Weinstein JN; Myers T; Buolamwini J; Raghavan K; van Osdol W; Licht J; Viswanadhan VN; Kohn KW; Rubinstein LV; Koutsoukos AD
    Stem Cells; 1994 Jan; 12(1):13-22. PubMed ID: 8142917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of in vitro and in vivo activities in the National Cancer Institute's anticancer screen with respect to chemical structure, target specificity, and mechanism of action.
    Huang R; Wallqvist A; Covell DG
    J Med Chem; 2006 Mar; 49(6):1964-79. PubMed ID: 16539384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenomic analysis: correlating molecular substructure classes with microarray gene expression data.
    Blower PE; Yang C; Fligner MA; Verducci JS; Yu L; Richman S; Weinstein JN
    Pharmacogenomics J; 2002; 2(4):259-71. PubMed ID: 12196914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of non-cross-resistant platinum compounds with novel cytotoxicity profiles using the NCI anticancer drug screen and clustered image map visualizations.
    Fojo T; Farrell N; Ortuzar W; Tanimura H; Weinstein J; Myers TG
    Crit Rev Oncol Hematol; 2005 Jan; 53(1):25-34. PubMed ID: 15607933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Data mining the NCI cancer cell line compound GI(50) values: identifying quinone subtypes effective against melanoma and leukemia cell classes.
    Marx KA; O'Neil P; Hoffman P; Ujwal ML
    J Chem Inf Comput Sci; 2003; 43(5):1652-67. PubMed ID: 14502500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linking pathway gene expressions to the growth inhibition response from the National Cancer Institute's anticancer screen and drug mechanism of action.
    Huang R; Wallqvist A; Thanki N; Covell DG
    Pharmacogenomics J; 2005; 5(6):381-99. PubMed ID: 16103895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer Drug Development: New Targets for Cancer Treatment.
    Curt GA
    Oncologist; 1996; 1(3):II-III. PubMed ID: 10387987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecules for the millennium: how will they look? New drug discovery year 2000.
    Sausville EA; Johnson JI
    Br J Cancer; 2000 Dec; 83(11):1401-4. PubMed ID: 11076644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Panel of human cancer cell lines provides valuable database for drug discovery and bioinformatics.
    Yamori T
    Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S74-9. PubMed ID: 12819939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on NCI in vitro drug screen utilities.
    Holbeck SL
    Eur J Cancer; 2004 Apr; 40(6):785-93. PubMed ID: 15120034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NCI's anticancer drug screening program may not be selecting for clinically active compounds.
    Brown JM
    Oncol Res; 1997; 9(5):213-5. PubMed ID: 9306428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell line-directed screening assay for inhibitors of thioredoxin reductase signaling as potential anti-cancer drugs.
    Kunkel MW; Kirkpatrick DL; Johnson JI; Powis G
    Anticancer Drug Des; 1997 Dec; 12(8):659-70. PubMed ID: 9448705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A protein expression database for the molecular pharmacology of cancer.
    Myers TG; Anderson NL; Waltham M; Li G; Buolamwini JK; Scudiero DA; Paull KD; Sausville EA; Weinstein JN
    Electrophoresis; 1997; 18(3-4):647-53. PubMed ID: 9150955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Web-based tools for mining the NCI databases for anticancer drug discovery.
    Fang X; Shao L; Zhang H; Wang S
    J Chem Inf Comput Sci; 2004; 44(1):249-57. PubMed ID: 14741034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. JFCR39, a panel of 39 human cancer cell lines, and its application in the discovery and development of anticancer drugs.
    Kong D; Yamori T
    Bioorg Med Chem; 2012 Mar; 20(6):1947-51. PubMed ID: 22336246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating drug efficacy and toxicology in three dimensions: using synthetic extracellular matrices in drug discovery.
    Prestwich GD
    Acc Chem Res; 2008 Jan; 41(1):139-48. PubMed ID: 17655274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and cytotoxicity of 1,2-disubstituted naphth[2,3-d]imidazole-4,9-diones and related compounds.
    Kuo SC; Ibuka T; Huang LJ; Lien JC; Yean SR; Huang SC; Lednicer D; Morris-Natschke S; Lee KH
    J Med Chem; 1996 Mar; 39(7):1447-51. PubMed ID: 8691475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benzethonium chloride: a novel anticancer agent identified by using a cell-based small-molecule screen.
    Yip KW; Mao X; Au PY; Hedley DW; Chow S; Dalili S; Mocanu JD; Bastianutto C; Schimmer A; Liu FF
    Clin Cancer Res; 2006 Sep; 12(18):5557-69. PubMed ID: 17000693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antineoplastic agents. 398. Isolation and structure elucidation of cephalostatins 18 and 19.
    Pettit GR; Tan R; Xu J; Ichihara Y; Williams MD; Boyd MR
    J Nat Prod; 1998 Jul; 61(7):955-8. PubMed ID: 9677284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxicity of the novel glutathione-activated thiopurine prodrugs cis-AVTP [cis-6-(2-acetylvinylthio)purine] and trans-AVTG [trans-6-(2-acetylvinylthio)guanine] results from the National Cancer Institute's anticancer drug screen.
    Gunnarsdottir S; Elfarra AA
    Drug Metab Dispos; 2004 Mar; 32(3):321-7. PubMed ID: 14977866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.